The abstract is read at the publisher; the summary is JClub's.
Non-negative matrix factorization of gene expression from 146 SCLC patient-derived xenograft models identifies six biologically distinct transcriptional subsets, including ASCL1-dominant, NEUROD1-dominant, co-active, and REST-active low-neuroendocrine groups.
- Why it matters: SCLC shows early metastasis and rapid therapy resistance, yet proposed subtype schemes based on lineage factors and inflammation need clearer biological separation tied to therapeutic programs and outcomes.
- What they did: The study applies NMF to 146 SCLC PDX gene-expression datasets, then uses a random forest classifier to map the resulting clusters onto 7 genetic mouse models, human cell lines, and IMpower133 patient data.
- The result: The inferred subsets differ in MYC family expression, transcription factor activation, antigen presentation programs, and cell-surface therapeutic target expression, enabling cluster-to-model and cluster-to-patient response linkage.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.